Brought to you by 
Google partners smart lens technology with Novartis
31 Aug 2015
Executive Summary
Google Inc.’s Google X unit licensed Novartis AG’s Alcon Inc. rights to its smart lens technology in ophthalmic areas, including contact and intraocular lenses. Novartis also says it plans to use the IP to help map diseases and figure out ways to prevent them.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Glucose Testing
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Google partners smart lens technology with Novartis
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice